Position in GRFS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$70,800
-$9,496 QoQ
Shares Held
10,000
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#107
of 164 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cordgrass Capital Advisors, LLC holds $11,857,226 across 8 Drug Manufacturers - General names. GRFS ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
20,326 | $5,162,194 | |
| 2 | PFE |
Pfizer Inc
|
68,388 | $1,646,783 | |
| 3 | MRK |
Merck & Co., Inc.
|
12,276 | $1,577,466 | |
| 4 | LLY |
ELI LILLY & Co
|
1,178 | $1,412,928 | |
| 5 | ABBV |
AbbVie Inc.
|
3,945 | $992,719 | |
| 6 | AMGN |
Amgen Inc
|
1,575 | $570,339 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,356 | $423,997 | |
| 8 | GRFS |
Grifols SA
This page
|
10,000 | $70,800 |
All Filings in GRFS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,800 | 10,000 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $80,296 | 10,012 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||